Reddy’s Lab slumps 15%; receives warning letter from USFDA
The company has received a warning letter from the US Food and Drug Administration (FDA) over inadequate quality control procedures at three of its drug manufacturing plants in Srikakulam, Miryalaguda and Duvvada.